Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 30 Jun 2026 for Natera, Inc.. Read the official filing
Filing timeline
BuySaleRoy D. Baynes
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Roy D. Baynes: trading record in brief
Roy D. Baynes, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Natera, Inc., Travere Therapeutics, Inc. and Atara Biotherapeutics, Inc. Over a trading history stretching from 14 May 2021 to 26 June 2026, the count stands at 47 filings.
On the market, this insider has only sold: 4 sales, €1.4M in total. The totals do not cover 1 filing with an undisclosed amount. The rest of the record consists of 29 share grants and 14 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
Most recently, on 30 June 2026, the filings show a share grant in Natera, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Roy D. Baynes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
1,571 sharesCommon StockSEC:0001680739-26-000015:0
75 sharesCommon StockSEC:0001680739-26-000015:1
4,500 sharesCommon StockSEC:0001680739-26-000014:0
4,500 sharesCommon StockSEC:0001680739-26-000014:1
4,000 shares0Common StockSEC:0001680739-26-000012:0
83 sharesCommon StockSEC:0001680739-26-000006:0
8,000 shares@ US$17.940.0026% mcap4.7% of flowCommon StockSEC:0001680739-26-000005:0
9,000 shares@ US$15.430.0025% mcap4.5% of flowCommon StockSEC:0001680739-26-000005:1
4,500 shares@ US$18.270.0015% mcap2.7% of flowCommon StockSEC:0001680739-26-000005:2
4,500 shares@ US$21.380.0017% mcap3.2% of flowCommon StockSEC:0001680739-26-000005:3
6,750 shares@ US$17.110.0021% mcap3.8% of flowCommon StockSEC:0001680739-26-000005:4
26,000 shares@ US$41.070.019% mcap35.0% of flowCommon StockSEC:0001680739-26-000005:5
6,750 shares@ US$42.120.0051% mcap9.3% of flowCommon StockSEC:0001680739-26-000005:6
10,000 shares@ US$26.520.0058% mcap24.1% of flowCommon StockSEC:0001680739-26-000003:0
10,000 shares@ US$33.000.0072% mcap30.0% of flowCommon StockSEC:0001680739-26-000003:1
70 sharesCommon StockSEC:0001680739-26-000001:0
5,112 shares@ US$40.9324.7% of flowCommon StockSEC:0001680739-25-000007:0
93 sharesCommon StockSEC:0001680739-25-000005:0
108 sharesCommon StockSEC:0001415889-25-020514:0
2,143 sharesCommon StockSEC:0001415889-25-018834:0
6,500 shares0Common StockSEC:0001415889-25-013496:0
116 sharesCommon StockSEC:0001415889-25-011550:0
10,000 shares@ US$17.4417.6% of flowCommon StockSEC:0001415889-25-003529:0
92 sharesCommon StockSEC:0001415889-25-003068:0
16,000 shares@ US$17.5028.2% of flowCommon StockSEC:0001415889-25-002003:0
25 of 47 declarations
